Regeneron Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 2.64, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Regeneron Pharmaceuticals Inc in Sep 30 2026 quarter, has decreased to 138 days, compared to 139 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 487 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3074, from overall ranking in the second quarter 2026 at 3539.

What is Receivable Turnover Ratio?
What is Regeneron Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

REGN Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	33.26 %	17.03 %	3.06 %	-7.58 %	-6.88 %
Y / Y Revenue Change	36.27 %	16.73 %	19.04 %	2.51 %	0.9 %
Receivable Turnover Ratio (TTM)	2.64	2.62	2.62	2.54	2.47
REGN's Total Ranking	# 3074	# 3539	# 3152	# 3201	# 3264
Accounts Receivable average collection period days	138	139	139	144	148
Seq. Receivable Change	15.43 %	14.56 %	-0.18 %	0.95 %	1.37 %
Seq. Revenue Change	19.23 %	19.01 %	-7.18 %	3.46 %	2.14 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 159
Healthcare Sector	# 488
Overall Market	# 3074

Receivable Turnover Ratio Statistics
High	Average	Low
145.94	16.97	2.33
(Jun 30 2011)		(Dec 31 2022)

REGN Company Profile • Back to REGN Efficiency Comparisons • Compare REGN Receivables Turnover Ratio to its Competitors

Financial Statements
Regeneron Pharmaceuticals Inc 's Accounts Receivable	$ 7,579 Millions	Visit REGN's Balance sheet
Regeneron Pharmaceuticals Inc 's Sales TTM	$ 16,896 Millions	Visit REGN's Income Statement
Sources of REGN's Revenues		Visit REGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
REGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
REGN's Growth Rates	REGN's Roa	REGN's Inventory Turnover Ratio	REGN's Dividend Comparisons
REGN's Profitability Ratios	REGN's Roi	REGN's Asset Turnover Ratio	REGN's Dividend Growth
REGN's Valuation Ratios	REGN's Roe	REGN's Financial Strength Ratios	REGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Vertex Pharmaceuticals Inc	6.10	$ 12,951.600 Millions	$ 2,123.550 Millions
Mimedx Group Inc	6.06	$ 303.363 Millions	$ 50.077 Millions
Rxsight Inc	6.00	$ 122.088 Millions	$ 20.336 Millions
Avantor Inc	5.98	$ 6,635.600 Millions	$ 1,110.300 Millions
Msa Safety Inc	5.96	$ 2,015.730 Millions	$ 338.388 Millions
Bio rad Laboratories Inc	5.92	$ 2,593.000 Millions	$ 437.800 Millions
Illumina Inc	5.87	$ 4,538.000 Millions	$ 773.500 Millions
Resmed Inc	5.82	$ 5,743.164 Millions	$ 986.765 Millions
Conmed Corporation	5.76	$ 1,369.288 Millions	$ 237.544 Millions
Clearpoint Neuro Inc	5.75	$ 45.493 Millions	$ 7.906 Millions
Davita Inc	5.75	$ 14,167.545 Millions	$ 2,462.529 Millions
Strata Critical Medical Inc	5.71	$ 236.425 Millions	$ 41.435 Millions
Standard Biotools Inc	5.69	$ 83.592 Millions	$ 14.699 Millions
Pacific Health Care Organization Inc	5.66	$ 6.368 Millions	$ 1.124 Millions
Dentsply Sirona Inc	5.64	$ 3,575.000 Millions	$ 633.750 Millions
Jazz Pharmaceuticals Plc	5.52	$ 4,718.126 Millions	$ 855.412 Millions
Community Health Systems Inc	5.51	$ 11,653.000 Millions	$ 2,115.250 Millions
Emergent Biosolutions Inc	5.49	$ 649.100 Millions	$ 118.325 Millions
Alnylam Pharmaceuticals Inc	5.48	$ 5,013.242 Millions	$ 914.792 Millions
Johnson and Johnson	5.45	$ 99,335.000 Millions	$ 18,233.000 Millions
Viskase Holdings inc	5.43	$ 271.837 Millions	$ 50.050 Millions
Incyte Corporation	5.42	$ 6,010.754 Millions	$ 1,109.534 Millions
Rigel Pharmaceuticals Inc	5.38	$ 288.213 Millions	$ 53.552 Millions
Integer Holdings Corporation	5.38	$ 1,825.122 Millions	$ 339.414 Millions
Ardelyx inc	5.37	$ 468.220 Millions	$ 87.120 Millions
Cryoport inc	5.32	$ 192.439 Millions	$ 36.205 Millions
Ptc Therapeutics inc	5.26	$ 1,155.554 Millions	$ 219.663 Millions
Repligen Corp	5.21	$ 805.610 Millions	$ 154.771 Millions
Biomerica Inc	5.17	$ 4.338 Millions	$ 0.838 Millions
Indivior Pharmaceuticals Inc	5.14	$ 1,376.000 Millions	$ 267.500 Millions

Date modified: 2026-10-31T17:28:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.